Tivic Health names COO, collaborates with Mount Sinai on pain trial, shifts HQ to Hayward

Valion Bio, Inc.

Ryan Sabia appointed COO effective Dec 21, 2021; base salary $250,000/yr plus up to 25% bonus.
Board approved annual director compensation plan: $35,000 retainer plus additional fees for chair roles.
Collaborating with Icahn School of Medicine at Mount Sinai for double-blind RCT on bioelectronic post-surgery pain management.
Principal place of business moved to 25821 Industrial Blvd, Suite 100, Hayward, CA 94545.
Mindgruve named digital marketing agency of record to support ecommerce and brand strategy.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ryan Sabia

Chief Operating Officer

VBIO · Valion Bio, Inc.

Effective: 2021-12-21
Filed: December 22, 2021, 6:59 PM ET

On December 21, 2021, the Company’s Board of Directors appointed Ryan Sabia, 35 years of age, as the Company’s Chief Operating Officer (“COO”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Sabia was appointed as Chief Operating Officer at Valion Bio, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On December 21, 2021, the Company’s Board of Directors appointed Ryan Sabia, 35 years of age, as the Company’s Chief Operating Officer (“COO”).

View on SEC.gov

Valion Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-21-152721

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.